Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

5.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.5K
Autoimmune Disorders01:29

Autoimmune Disorders

806
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
806
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

15
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
15
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

25
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
25
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

285
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
285
The Thyroid Gland01:23

The Thyroid Gland

4.7K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The microbiological profile of patients with Fournier's gangrene: A retrospective multi-institutional cohort study.

Urologia·2021
Same author

Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2021
Same author

The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.

Urologia internationalis·2021
Same author

Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263].

European urology oncology·2021
Same author

Cytokines as Targets of Novel Therapies for Graves' Ophthalmopathy.

Frontiers in endocrinology·2021
Same author

Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.

Therapeutic advances in urology·2021

Related Experiment Video

Updated: Oct 11, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.0K

Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism.

Silvia Martina Ferrari1, Francesca Ragusa1, Giusy Elia2

  • 1Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Frontiers in Pharmacology
|December 6, 2021
PubMed
Summary

Autoimmune thyroid diseases like Hashimoto's and Graves' can be managed with levothyroxine (L-T4) and newer treatments like myoinositol. Personalized medicine approaches, including potential surgical options, are improving patient quality of life.

Keywords:
Hashimoto’s thyroiditisautoimmune thyroid disordersautoimmune thyroiditishypothyroidismlevothyroxinethyroidectomy

More Related Videos

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

773
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.8K

Related Experiment Videos

Last Updated: Oct 11, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.0K
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

773
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.8K

Area of Science:

  • Endocrinology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune thyroid diseases (AITD) involve T-cell-mediated attacks on the thyroid, leading to Hashimoto's thyroiditis (hypothyroidism) or Graves' disease (thyrotoxicosis).
  • Standard treatment for hypothyroidism involves daily synthetic levothyroxine (L-T4), with various formulations available to address absorption issues.

Purpose of the Study:

  • To review current evidence on personalized medicine strategies for autoimmune thyroiditis and hypothyroidism.
  • To highlight emerging treatments and their impact on patient outcomes and quality of life.

Main Methods:

  • Review of clinical studies and randomized trials on AITD management.
  • Analysis of the role of myoinositol and selenium in thyroid autoimmunity.
  • Evaluation of surgical interventions like thyroidectomy for specific indications.

Main Results:

  • Myoinositol combined with selenium has shown a significant reduction in TSH and antithyroid autoantibodies in subclinical hypothyroidism.
  • Total thyroidectomy may improve quality of life and reduce fatigue compared to medical therapy in some cases.
  • L-T4 formulations vary in efficacy based on patient absorption and drug interactions.

Conclusions:

  • Personalized medicine offers promising avenues for managing autoimmune thyroiditis and hypothyroidism.
  • Further large-scale research is necessary to fully understand the long-term effects of novel treatments on quality of life.
  • Individualized treatment plans, considering factors beyond hormone replacement, are crucial for optimal patient care.